SEC Form 4 · accession 0001123292-15-000747
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francis Willard Sarena
Officer — SVP, Gen Counsel & Secretary
Period of report
Apr 30, 2015
Accepted (ET)
May 4, 2015 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 30, 2015 | A | 6,110 | $0.00 | A | 8,570 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of restricted stock, which will vest fully on January 3, 2017, provided the reporting person remains employeed by the Company.
- F2Reflects the acquisition of 2,460 shares on May 15, 2014 pursuant to the Five Prime Therapeutics, Inc. 2013 Employee Stock Purchase Plan.